Literature DB >> 1866765

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

P A Wolf1, R D Abbott, W B Kannel.   

Abstract

The impact of nonrheumatic atrial fibrillation, hypertension, coronary heart disease, and cardiac failure on stroke incidence was examined in 5,070 participants in the Framingham Study after 34 years of follow-up. Compared with subjects free of these conditions, the age-adjusted incidence of stroke was more than doubled in the presence of coronary heart disease (p less than 0.001) and more than trebled in the presence of hypertension (p less than 0.001). There was a more than fourfold excess of stroke in subjects with cardiac failure (p less than 0.001) and a near fivefold excess when atrial fibrillation was present (p less than 0.001). In persons with coronary heart disease or cardiac failure, atrial fibrillation doubled the stroke risk in men and trebled the risk in women. With increasing age the effects of hypertension, coronary heart disease, and cardiac failure on the risk of stroke became progressively weaker (p less than 0.05). Advancing age, however, did not reduce the significant impact of atrial fibrillation. For persons aged 80-89 years, atrial fibrillation was the sole cardiovascular condition to exert an independent effect on stroke incidence (p less than 0.001). The attributable risk of stroke for all cardiovascular contributors decreased with age except for atrial fibrillation, for which the attributable risk increased significantly (p less than 0.01), rising from 1.5% for those aged 50-59 years to 23.5% for those aged 80-89 years. While these findings highlight the impact of each cardiovascular condition on the risk of stroke, the data suggest that the elderly are particularly vulnerable to stroke when atrial fibrillation is present.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1866765     DOI: 10.1161/01.str.22.8.983

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  1693 in total

Review 1.  New devices and hybrid therapies and new devices for treatment of atrial fibrillation.

Authors:  R B Krol; S Saksena; A Prakash
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

2.  Policy dilemmas for oral anticoagulation management.

Authors:  D A Fitzmaurice; J P Raftery; S Bryan
Journal:  Br J Gen Pract       Date:  2000-10       Impact factor: 5.386

3.  Relationship between left atrial spontaneous echo contrast and the features of middle cerebral artery territory in nonvalvular atrial fibrillation.

Authors:  K Kochi; K Kanehiro; K Mukada; J Hasada; S Kajihara; K Orihashi; T Sueda; Y Matsuura
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

4.  Managing atrial fibrillation in elderly people.

Authors:  K M English; K S Channer
Journal:  BMJ       Date:  1999-04-24

5.  Determinants of successful direct current cardioversion for atrial fibrillation and flutter: the importance of rapid referral.

Authors:  A R Houghton; A Sharman; J E Pohl
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

6.  Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy.

Authors:  M Man-Son-Hing; A Laupacis; A M O'Connor; R G Hart; G Feldman; J L Blackshear; D C Anderson
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

Review 7.  The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.

Authors:  C Sarti; M Kaarisalo; J Tuomilehto
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

Review 8.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

9.  Atrial fibrillation: an important issue for African Americans?

Authors:  Julian Haywood
Journal:  J Natl Med Assoc       Date:  2002-04       Impact factor: 1.798

Review 10.  Very low-intensity antithrombotic therapy in atrial fibrillation.

Authors:  B G Koefoed; P Petersen
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.